Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNBELIEVABLE: 7 - Caught on Camera

H1N1 Cases Are Surging: 5 Things Nobody Tells You

A fever, cough and body ache can easily look like an ordinary seasonal illness. But when H1N1 cases begin rising across Delhi, one question naturally comes to mind: Is this something to fear? The answer is more reassuring than the headlines may suggest. Health authorities have said that no new…

MyLifeXP

Indian Council of Medical Research says no new H1N1 strain detected; urges no panic

The Indian Council of Medical Research has confirmed no new H1N1 strain exists in India. Current circulating viruses belong to a known A/Missouri/11/2025 strain, which matches vaccine recommendations. Delhi has reported over 2,600 influenza cases, including 1,777 H1N1 cases recently. Health authorities are monitoring the situation and advising public hygiene…

The Economic Times

How Fruit Bats in Kerala Triggered India's 2018 Nipah Outbreak and What It Revealed About Zoonotic Spillover

The Kozhikode Cluster That Alarmed EpidemiologistsIn May 2018, seventeen people died in Kozhikode district within weeks of each other. The deaths came fast and with alarming symptoms: sudden fever, disorientation, and in several cases, acute encephalitis. The Kerala health department, working with the National Institute of Virology in Pune, confirmed…

Times Life

From analysis to the latest developments in health,
read the most diverse news in one place.

‘Devastating’: Western Australia fears a black swan moment as bird flu threatens flagship species

The state’s bird emblem is an indicator species for H5N1, with high visibility populations and low survival rates. Experts are warning of ‘significant mortality’

The Guardian - AU

Experts raise alarm over Trump’s public consultation on vaccines policy

Asking people to weigh in on adoption of different categories in move that will sow confusion and create access challenges, say experts

The Guardian - US

NVAX Stock Alert: Biotechs Hit Post-Pandemic High on mRNA Cancer Breakthrough

NVAX stock surges amid biotech stock rally following Moderna and Merck cancer breakthrough.

Barchart

What Trump’s push for fewer vaccines could mean for US children

The U.S. Department of Health and Human Services is seeking public comments on vaccine recommendations. This review follows President Donald Trump's directive to examine childhood immunization schedules. The department is exploring new ways to classify and communicate vaccine guidance. Feedback is being gathered on shared decision-making and public trust concerns.…

The Economic Times

Read news from The Economist, FT, and more,
with one subscription

HHS seeks input on kids vaccination changes called for by Trump

The Department of Health and Human Services on Friday outlined potential changes to the childhood vaccine schedule, suggesting kids shots should be spread farther apart in contrast to recommendations from pediatric groups. The request for information fulfills directives outlined in President Donald Trump’s executive order from Aug. 10 that seeks to stagger vaccine…

Roll Call

Australian Data Put the Maternal RSV Vaccine at 78 Percent Effective Against Infant Lung Infection Admissions

A JAMA Pediatrics study of 1,012 hospitalized infants found maternal RSV vaccine effectiveness to be 77.8% against lung infection admissions through six months.

Medical Daily

Why millions of people around the world will contract measles in 2026

The World Health Organization estimates that in 2026 nearly 11 million people will contract the virus that causes measles. Most of these cases will occur in Africa and Asia, but many countries in the Americas and Europe are reporting outbreaks affecting hundreds or thousands of people.

The Conversation

New CDC Chief Tells Staff She Will Challenge Kennedy Privately While Funded Programs Sit Without People

In her first all-hands meeting, CDC Director Erica Schwartz acknowledged understaffed programs and burnout and said she would disagree with Kennedy privately.

Medical Daily

Moderna’s 177% Surge Has Investors Asking What Comes Next

Moderna shares surged 177% after its melanoma vaccine, developed with Merck, outperformed an established therapy in a late-stage trial, triggering a massive short squeeze.

MarketBeat

Moderna, Merck's Cancer Vaccine Breakthrough Raises Hope For New Wave Of Personalized Treatments

Moderna and Merck's experimental cancer vaccine has delivered positive results in a late-stage melanoma trial, giving a major boost to personalized mRNA treatments as rivals including BioNTech and Roche pursue similar approaches.

International Business Times

Moderna's Vaccine Breakthrough Supported by AI: Musk Praises mRNA Despite 'Obvious Misuse During COVID'

Moderna and Merck's personalised mRNA vaccine shows promising Phase 3 results in melanoma treatment, potentially revolutionising cancer care with tailored immunotherapy.

International Business Times UK

Get all your
news in one place.

100's of premium titles.
One news app.

Times Life

Horseshoe Crab Blood Powers Every Vaccine and Injection You Have Ever Been Given

The blue blood that guards every hospital on EarthHorseshoe crab blood is blue. Not metaphorically, literally blue, because it uses copper-based hemocyanin to carry oxygen instead of the iron-based hemoglobin that makes human blood red. But the colour is not why the biomedical industry harvests roughly 600,000 horseshoe crabs every…

Medical Daily

Vaccinated Measles Patients Occasionally Infect Others, and Contact Tracers Are Now Being Urged Not to Rule Them Out

A review of 33 reports found that 7.9% of vaccinated measles patients transmitted the virus. Most had a milder illness. What does it mean for families?

The Guardian - UK

The Guardian view on Trump’s MMR executive order: endangering the children he claims to care about

Editorial: The president’s empty advice that children should receive separate jabs against measles, mumps and rubella will only lead to less take-up by parents

Radio France Internationale

Five years on from first vaccine, fight against malaria sees progress in Africa

On World Mosquito Day, attention remains focused on the devastating impact of the disease in Africa. The continent accounts for 95 per cent of malaria-related deaths worldwide. Five years after the roll-out of the first malaria vaccine, it is beginning to deliver measurable results – although significant challenges remain.

Get all your
news in one place.

100's of premium titles.
One news app.

Roll Call

Republicans revive false miscarriage statistic, twist Fauci’s texts about COVID-19 shots

By Kate Yandell ANALYSIS — Studies have shown no connection between COVID-19 vaccination during pregnancy and increased risk of miscarriage. Despite this, Republican Sens. Rand Paul and Ron Johnson resurrected a long-debunked claim of an astronomical rate of miscarriage after vaccination while also accusing Dr. Anthony Fauci of deceiving the…

Euronews

DR Congo to receive 70,000 doses of Ebola vaccine used in past outbreaks, WHO says

The International Coordinating Group on Vaccine Provision, which includes the WHO and other partners, said the doses will be released immediately following a request from DR Congo’s government.

Medical Daily

Flu and COVID Vaccines Are Expected This Fall with Insurer Coverage Despite a Stalled Federal Advisory Committee

Infectious disease specialists say updated flu and COVID vaccines will be available and covered this fall even though the federal advisory panel has not acted.

The Independent UK

Congo to receive 70,000 doses of Ervebo Ebola vaccine which has been effective in past outbreaks

The World Health Organization says Congo will receive 70,000 doses of the Ervebo vaccine

The Independent UK

How does Moderna’s new melanoma vaccine work – and could it treat other cancers?

Melanoma is the most aggressive form of skin cancer causing about 2,600 deaths a year in the UK

International Business Times UK

Short Sellers Just Lost $5B on the Wrong Pharma Bet: Cancer Vaccine Sends Stock Soaring 177%

Moderna's shares surged 177% after positive cancer vaccine trial results, causing $5 billion losses for short sellers. This marks a potential shift beyond its COVID-19 vaccine business.

International Business Times UK

Moderna's Personalised Cancer Vaccine Clears Phase 3: How Soon Could Patients Receive It?

Moderna and Merck's personalised cancer vaccine shows positive Phase 3 results, reducing melanoma recurrence risk. Regulatory approval is pending, with potential market availability by 2027.

1 … 6 7 8 9

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organization

the Department of Health and Human Services

156 stories

ICMR

125 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.